OptimizeRx
OPRX · NASDAQ
About OPRX
- Employees
- 104
- Headquarters
- Waltham, Massachusetts
- Listed
- May 18, 2005
- Sector
- Health Care
- Industry
- Health Care Technology
- Website
- optimizerx.com
OPRX key statistics
- Market cap
- 164.63M
- Price-earnings ratio
- 38.00
- Dividend yield
- —
- Average volume
- 182.80K
- Volume
- 157.75K
- Open price
- $8.71
- High today
- $9.08
- Low today
- $8.57
- 52 Week high
- $22.25
- 52 Week low
- $4.54
OptimizeRx (OPRX) at a glance
OptimizeRx (OPRX) last traded at $8.93, with a market cap of 164.63M and a price-to-earnings ratio of 38.00.
Today the stock has traded between $8.57 and $9.08. The current price is 4.2% above the day's low and 1.7% below its high.
Volume so far is 157.75K shares, in line with the average of 182.80K shares a day.
Over the past year OptimizeRx has ranged from $4.54 to $22.25, and now sits 25% of the way up that range.
OptimizeRx met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $0.16 per share against an estimate of $0.0796.
The average analyst price target is $12.85, 43.9% above the current price, from 7 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy85.7%
- Hold14.3%
- Sell0.0%
- Low
- $11.11
- Now
- $8.93
- High
- $18.90
OPRX earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 8 of the last 8 quarters, by 319.5% on average.
- Q3 FY24: reported $0.12 per share against an estimate of $0.0629
- Q4 FY24: reported $0.30 per share against an estimate of $0.2767
- Q1 FY25: reported $0.08 per share against an estimate of -$0.1224
- Q2 FY25: reported $0.24 per share against an estimate of $0.0175
- Q3 FY25: reported $0.20 per share against an estimate of $0.0452
- Q4 FY25: reported $0.51 per share against an estimate of $0.2312
- Q1 FY26: reported $0.14 per share against an estimate of -$0.0393
- Q2 FY26: reported $0.16 per share against an estimate of $0.0796
OPRX news
OptimizeRx Reports Q1 2026 Results: Full Earnings Call Transcript
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releaseBusiness Wire
Myomo Appoints William J Febbo to its Board of Directors
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Assessing OptimizeRx: Insights From 4 Financial Analysts
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Thursday's After-Market Session
Similar companies
Companies in the same industry as OptimizeRx
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.